梅花生物：梅花生物2023年年度报告（英文版）.PDF

1、Annual Report 2023 1/282 Company Code:600873 Short name:Meihua Bio Meihua Holdings Group Co.,Ltd.Annual Report 2023 This is an English translation from the Annual Report 2023,in case of any inconsistency,the Chinese Version shall prevail.Annual Report 2023 2/282 Important Information I.The Companys

2、board of directors,board of supervisors,directors,supervisors,and officers guarantee that the contents of this annual report are true,accurate,and complete without any false records,misleading statements,or material omissions and bear joint and several legal liability.II.All of the Companys director

3、s have attended the board meeting.III.Da Hua CPAs LLP(special general partnership)has issued an unqualified audit report for the Company.IV.Wang Aijun,the principal of the Company,Wang Lihong,the accounting principal,and Wang Ailing,the principal of the accounting body(the accounting officer),hereby

4、 declare that they guarantee the truthfulness,accuracy,and completeness of the financial report in the annual report.V.Profit distribution plan or capital reserve conversion plan for the Reporting Period as approved by the Board Upon deliberation and approval of the 9th meeting of the 10th session o

5、f the board of directors,the profit distribution plan(proposal)for 2023 is as follows:with the total share capital registered on the registration date of equity distribution as the basis(before deducting the number of shares in the share repurchase account,the Company has a total of 2,943,426,102 sh

6、ares in share capital;there are 69,634,252 shares in the share repurchase account,and after deducting those shares,the number of shares is 2,873,791,850),a dividend of 4.17 yuan(inclusive of tax)for every 10 shares is to be distributed to all shareholders,and a total of approximately 1.2 billion yua